GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Escalon Medical Corp (OTCPK:ESMC) » Definitions » Asset Turnover

ESMC (Escalon Medical) Asset Turnover : 0.59 (As of Sep. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Escalon Medical Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Escalon Medical's Revenue for the three months ended in Sep. 2024 was $2.78 Mil. Escalon Medical's Total Assets for the quarter that ended in Sep. 2024 was $4.74 Mil. Therefore, Escalon Medical's Asset Turnover for the quarter that ended in Sep. 2024 was 0.59.

Asset Turnover is linked to ROE % through Du Pont Formula. Escalon Medical's annualized ROE % for the quarter that ended in Sep. 2024 was -7.14%. It is also linked to ROA % through Du Pont Formula. Escalon Medical's annualized ROA % for the quarter that ended in Sep. 2024 was -2.70%.


Escalon Medical Asset Turnover Historical Data

The historical data trend for Escalon Medical's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Escalon Medical Asset Turnover Chart

Escalon Medical Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.73 1.84 1.97 2.32 2.38

Escalon Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.60 0.58 0.74 0.59

Competitive Comparison of Escalon Medical's Asset Turnover

For the Medical Devices subindustry, Escalon Medical's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Escalon Medical's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Escalon Medical's Asset Turnover falls into.



Escalon Medical Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Escalon Medical's Asset Turnover for the fiscal year that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jun. 2024 )/( (Total Assets (A: Jun. 2023 )+Total Assets (A: Jun. 2024 ))/ count )
=11.982/( (5.308+4.758)/ 2 )
=11.982/5.033
=2.38

Escalon Medical's Asset Turnover for the quarter that ended in Sep. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=2.781/( (4.758+4.719)/ 2 )
=2.781/4.7385
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Escalon Medical  (OTCPK:ESMC) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Escalon Medical's annulized ROE % for the quarter that ended in Sep. 2024 is

ROE %**(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=-0.128/1.7935
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.128 / 11.124)*(11.124 / 4.7385)*(4.7385/ 1.7935)
=Net Margin %*Asset Turnover*Equity Multiplier
=-1.15 %*2.3476*2.642
=ROA %*Equity Multiplier
=-2.70 %*2.642
=-7.14 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Escalon Medical's annulized ROA % for the quarter that ended in Sep. 2024 is

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=-0.128/4.7385
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.128 / 11.124)*(11.124 / 4.7385)
=Net Margin %*Asset Turnover
=-1.15 %*2.3476
=-2.70 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Escalon Medical Asset Turnover Related Terms

Thank you for viewing the detailed overview of Escalon Medical's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Escalon Medical Business Description

Traded in Other Exchanges
N/A
Address
435 Devon Park Drive, Suite 824, Wayne, PA, USA, 19087
Escalon Medical Corp operates in the healthcare market specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its products are A-Scans, B-Scans, UBM, Pachymeters, Ispan Intraocular Gases, Surgical Packs, Viscous Fluid Transfer Systems, and AXIS Image Management. Substantial revenue is generated from the domestic sales of products.
Executives
David James Jacovini director 120 PINE STREET, PHILADELPHIA PA 19106
John Dogum director 1818 MARKET STREET, 35TH FLOOR, PHILADELPHIA PA 19103
Richard J Depiano director 435 DEVON PARK DRIVE, SUITE 100, WAYNE PA 19087
Lisa A Napolitano director 351 EAST CONESTOGA ROAD, WAYNE PA 19087
C Sean Closkey director 1700 MARKET STREET, 19TH FLOOR, PHILADELPHIA PA 19103
C Todd Trusk director 1410 RUSSELL ROAD, SUITE 100, WAYNE PA 19301
Robert Michael O'connor officer: Chief Financial Officer 53 SORREL RUN, MT. LAUREL NJ 08054
Anthony J Coppola director 1 NORTH NEW YORK ROAD, SMITHVILLE NJ 08205
Federman Jay L Md director 501 N. ESSEX AVENUE, NARBERTH PA 19072
Kwan William L G director 351 EAST CONESTOGA ROAD, WAYNE PA 19087
Mark Wallace officer: Chief Operating Officer 565 E SWEDESFORD ROAD, STE 200, WAYNE PA 19087
Fred G Choate director 601 DELSEA DRIVE, WASHINGTON TOWNSHIP NJ 08080
Depiano Richard J Jr officer: President 575 E. SWEDESFORD ROAD, SUITE 100, WAYNE PA 19087
Berkowitz David officer: Principal Accounting Officer 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087
Mark H Karsch officer: CFO 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087

Escalon Medical Headlines